Area of research
Oncology · Cancer Research
Research interest
Research interests include Cancer research, Glioma, Neutrophil extracellular traps, Cell biology, Chemistry, and Platelet.
Platelet-derived microparticles stimulated by anti-β <sub>2</sub> GPI/β <sub>2</sub> GPI complexes induce pyroptosis of endothelial cells in antiphospholipid syndrome
Neutrophil extracellular traps mediate the crosstalk between glioma progression and the tumor microenvironment <i>via</i> the HMGB1/RAGE/IL-8 axis
Dual functionalized brain-targeting nanoinhibitors restrain temozolomide-resistant glioma via attenuating EGFR and MET signaling pathways
ATRX/EZH2 complex epigenetically regulates FADD/PARP1 axis, contributing to TMZ resistance in glioma
NoncoRNA: a database of experimentally supported non-coding RNAs and drug targets in cancer
Tumor Cell–Derived TGFβ1 Attenuates Antitumor Immune Activity of T Cells via Regulation of PD-1 mRNA
DNA damage repair alterations modulate M2 polarization of microglia to remodel the tumor microenvironment via the p53-mediated MDK expression in glioma
Anti‐β2GPI/β2GPI induces human neutrophils to generate NETs by relying on ROS
Anti-β2GPI/β2GPI complexes induce platelet activation and promote thrombosis via p38MAPK: a pathway to targeted therapies
Anti-β2GPI/β2GPI induces neutrophil extracellular traps formation to promote thrombogenesis via the TLR4/MyD88/MAPKs axis activation
Platelets activated by the anti-β2GPI/β2GPI complex release microRNAs to inhibit migration and tube formation of human umbilical vein endothelial cells
Protective effects of tenuigenin on lipopolysaccharide and d -galactosamine-induced acute liver injury
Current research development of neutrophil extracellular traps related diseases